SBSagar Mahendrabhai Bhinde

Sagar Mahendrabhai Bhinde

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sagar Mahendrabhai Bhinde has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of Bhringaraja Arka as an Add–On to Standard Care in the Management of Neonatal Jaundice – A Study Protocol for an Open Labelled Randomized Controlled Clinical Trial

    by Sreesha M S, Bhinde Sagar M

    Background: Neonatal jaundice (NNJ) is common biochemical hyperbilirubinemia, affecting 85% of term and 95% of preterm infants in India. Mild cases are self-limiting, but severe NNJ (Serum Bilirubin > 15 mg/dL) remains a global concern, especially in low- and middle-income countries. Severe hyperbilirubinemia can cause long-term neurocognitive sequelae such as cerebral palsy, auditory neuropathy, deafness, and increased mortality. Current treatments include phototherapy, exchange transfusion, and phenobarbitone, although each has limitations. Phototherapy may lead to loose stools, dehydration, rashes, and retinal damage, whilst phenobarbitone can cause somnolence and dependence. Bhringaraja (Eclipta prostrata L.), traditionally used in Ayurveda for liver disorders and hyperbilirubinemia, has been investigated as a complementary therapy. It acts as a Rakta Shodhaka (blood purifier) and Pittahar (Pitta-balancer). Phytochemicals like wedelolactone and ecliptine provide hepatoprotective effects including, supporting hepatocyte function, metabolism, and bilirubin clearance. Despite its long traditional use in NNJ, scientific evaluation of efficacy is lacking.Methods: Eligible NNJ patients will be randomized into two groups (≥ 20 each). Group A will receive Bhringaraja Arka (5 drops 3×daily) plus standard care, while Group B will receive standard care alone (clinical observation and phototherapy if required). Treatment will continue for 7 days or until Serum Bilirubin reaches remission levels.Conclusion: This study protocol aims to produce a study which will generate evidence on the potential of Bhringaraja Arka to determine whether it accelerates recovery and prevent NNJ progression.

  • Open Access

    Evaluation of Physicochemical and Microbiological Properties of Ashokarohini Churna – A Polyherbal Formulation for Undernutrition of Children

    by Ravindra Prasad Weerasingha, Leena Illeperuma, Sagar Mahendrabhai Bhinde, Ruwani Kaushala Jayaratne, Thamara Kumari Nawarathna

    Background: Ashokarohini Churna (ARC) is a polyherbal formulation described in the Ashtanga Samgraha , a classical text of Ayurveda. It is traditionally used in pediatric practice for the management of undernutrition ( Karshya ) in children. Despite its therapeutic significance, there is limited scientific evidence regarding its quality parameters and safety profile. Aims and Objectives: This study aimed to evaluate the physicochemical parameters, microbiological properties, and chromatographic profile of Ashokarohini Churna (ARC) to establish preliminary quality standards. Materials and Methods: The formulation containing Picrorhiza kurroa Royle ex Benth and Piper longum Linn. was prepared following Good Manufacturing Practices (GMP). The prepared sample was subjected to physicochemical, microbial, and thin layer chromatography (TLC) analyses at the Quality Assurance, Research and Development Laboratory, Bandaranaike Memorial Ayurveda Research Institute, Nawinna, Maharagama, Sri Lanka. Results: The physicochemical parameters were recorded as follows: pH – 5.2; water-extractable matter – 27.1%; loss on drying – 11.7%; total ash – 4.2%; and acid-insoluble ash – 0.5%. Microbial analysis confirmed the absence of Escherichia coli, Shigella spp., and Salmonella spp. TLC analysis under 254 nm and 366 nm revealed five distinct spots at each wavelength, indicating the presence of multiple phytoconstituents. Conclusion: This study provides preliminary data on the physicochemical, chromatographic, and microbiological qualities of ARC. The established fingerprinting pattern can serve as a reference for future studies and quality control of this polyherbal formulation. Further research is recommended to develop comprehensive quality standards for ARC.

  • Open Access

    Efficacy of Kantakari Avaleha in the management of bronchial asthma in children: A randomized controlled clinical trial

    by Sagar M. Bhinde, Virendra K. Kori

    Background: Bronchial asthma is a chronic inflammatory condition of the lung airways resulting in episodic airflow obstruction. It is the most common chronic disease among children, ranking among the top 20 conditions worldwide for disability-adjusted life years in children. This highlights the need for traditional medicine in the long-term management of Asthma. Aim: To evaluate the efficacy of Kantakari Avaleha (KA) in the management of Tamaka Shwasa (bronchial asthma) in children. Materials and methods: The present study was open-labeled, randomized controlled clinical trial. A total of 104 patients of bronchial asthma were screened, out of which 100 patients were registered in the study. These patients were randomly allocated to either KA treated group A ( n = 50) or to Chitrakaharitaki Avaleha (CHA) treated control group B ( n = 50). Among them, 80 patients completed the trial along with follow-up, and 20 patients did not complete the trial. Results: After 8 weeks of treatment, use of KA (group A; n = 40) showed statistical significant improvement in most of the clinical features, Agni Bala (digestion power), peak expiratory flow rate (PEFR), respiratory rate (RR), breath holding time, level of asthma control (LAC), asthma control test (ACT) and in asthma control questionnaire (ACQ). CHA (Group B; n = 40) showed significant improvement in all the clinical features, digestion power, PEFR, RR, LAC, ACT, and in ACQ. On comparison of the groups, significant difference was found in breathlessness ( P = 0.006) , cold ( P = 0.021) , difficulty in speaking ( P = 0.018) , ACT ( P = 0.034), and ACQ ( P = 0.003) (Group B was better than Group A). No any adverse reaction was observed during the study period. Conclusion: Chitrakaharitaki Avaleha is more effective than Kantakari Avaleha in managing bronchial asthma in children.

  • Open Access

    Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study

    by Anup Thakar, Mandip Goyal, Sagar Bhinde, Yagnik Chhotala, Kalpesh Panara, Swapnil Chaudhari


  • Open Access

    Guduchi Ghanavati (Ayurveda medication) improves the perceived immunity in individuals at risk of SARS-CoV-2: A multicentred, controlled, before-and-after study

    by Anup Thakar, Kalpesh Panara, Harshit Shah, Bharat Kalsariya, Sweety Ruparel, Naresh Jain, Parthiv Bhatt, Dilip Jani, Rajendrasinh Dodia, Falgun Patel, et al.


  • A critical appraisal of Lakshanadhyaya of Kashyapa Samhita with special reference to pediatric examination

    by SagarM Bhinde, Aniket Shilwant

    Clinical, professional, social, and spiritual fortunes. But, Lakshanadhyaya is incomplete at the end. Objective: To reveal the clinical importance of features mentioned in Lakshanadhyaya and to provide probable justification for particular future predictions given in Lakshanadhyaya. Data Source: Lakshanadhyaya of Kashyapa Samhita published by Chaukhambha Sanskrit Sansthan, Varanasi. Materials and Methods: Relevant materials were searched from sources such as published books, journals, and the Internet. A critical review was done over the same. Result: Acharya Kashyapa has predicted the quality and quantity of life by assessment of anatomical and physiological features of the child from birth till adolescence. All clinical points such as signs of gestational maturity (by examining the skin, hair, movement, and genitals), anthropometry (size of body parts), secondary sex characters (such as pubic hair, breast, and genitals), and systemic examinations (such as per vaginal, per rectal, musculoskeletal, and per abdomen examinations) are covered in Lakshanadhyaya. Conclusion: This article highlights that time to time examination of a child helps to predict their future life. The abdomen, vagina, nail, scrotum, penis, hair, joints, back, gait, etc., are important areas of examination for early detection of impending clinical manifestation....


  • Open Access

    A compendious review of Chitraka Haritaki Avaleha – A polyherbal Ayurveda formulation for bronchial asthma

    by Sagar Mahendrabhai Bhinde, Virendra K Kori, Kalpana S Patel

    Introduction: Avaleha (confection) is an unique dosage form of Ayurvedic pharmaceutics, which is frequently prescribed in various disorders and especially in respiratory disorders. Chitraka Haritaki Avaleha (CHA) is one such formulation being used extensively by Ayurveda physicians for bronchial asthma, despite its classical use in various other disorders too. CHA was first time described by Vrindamadhava in the 9th century and had been amended for many times till today. Because of its demand, many pharmaceutical companies are also manufacturing it, and is freely available in the market. Aim: The aim is to screen and compile references pertaining to composition, method of preparation, therapeutic uses, organoleptic, and physico-chemical parameters of CHA from different classics and original research articles. Materials and methods: Description of CHA was extensively reviewed from Vrindamadhava, Chakradatta, Vangasena, Gadanigraha, Yogatarangini, Bhaishjya Ratnavali and Yogaratnakara. Synonyms, Rasapanchaka (Ayurveda principles of drug action), and Dosha Karma (therapeutic attributes) of ingredients were compiled from Bhavaprakasha Nighantu. Organoleptic and physicochemical parameters were compiled from original research articles, searched from PubMed, Google Scholar, and Research Gate. Results: Variations in formulation name, ingredients, method of preparation, therapeutic indications and Anupana (adjuvant) was observed in the classical texts. Value of water-soluble extracts and pH of analytical study was found different than Ayurveda Pharmacopeia of India standards. Conclusion: Screening through various texts revealed that CHA has been mentioned in seven classical treatises and two gazetted texts with amendments which indicate its high demand and clinical efficacy in bronchial asthma along with other diseases. Disparity found in analytical parameters indicates the need of standardization of pharmaceutical process.


  • Open Access

    Management of spastic cerebral palsy through multiple Ayurveda treatment modalities

    by Sagar M Bhinde, Kalpana S Patel, Virendra Kumar Kori, S Rajagopala

    Background: Cerebral palsy (CP) is a leading cause of childhood disability affecting function and development. The global incidence of CP is 2:1000. It has been reported that children with CP and their caretaker have impaired health-related quality of life (QOL). Of the many types and subtypes of CP, none has any known cure. For a detailed description of the disease CP, though, there is no one to one correlation in Ayurvedic classics; it can be taken as Vata Vyadhi as far as its etiology and symptomatology are concerned. Aim: To assess the effect of certain Panchakarma procedures in the management of CP. Materials and Methods: Total 8 patients were registered and treated with 5 days of Udvartana, 5 days of Abhyanga followed by Sarvanga Swedana and then 8 days of Yoga Basti. The same course of treatment has been repeated for 3 times with an interval of 14 days. Ashtanga Ghrita was given during whole procedures as internal medication. Results of treatment were assessed with anthropometrical measurement, developmental milestone, Modified Ashworth Scale, spasm scale, reflex scale, and muscle power grading. Result: This Ayurvedic management shows good result in CP patients, especially by improving growth (height, weight, chest circumference) and development (head holding and sitting), reducing spasticity of left upper limb and muscle spasm. Conclusion: Multisystem approach is needed to improve the condition of the patient. Panchakarma along with internal medication should be given to improve all the facets of spastic CP. Yoga Basti acts by their own mode of action and can be used freely for such disease conditions.